Green Elephant Biotech announces the market introduction of Archimedes® One, the first system in a new category called the Dynamic Adherent Bioreactor. The company is introducing the platform to the ...
Intermediate-scale benchtop bioreactor protocol streamlines production of iPSC-derived macrophages for research, drug discovery, and modeling.
Germany’s Green Elephant Biotech has announced the market introduction of Archimedes One, the first system in a new category ...
20hon MSN
Algae And Yeast For Skin? Biotech Skincare Could Compete With Korean Trends Any Day; Here's How
Biotech skincare could offer a competitive edge when targeted and personalised skincare is concerned. Here is what you need ...
Fermentation has evolved into precision fermentation, utilizing biotechnology to engineer microorganisms that produce ...
The technology is designed to simplify the bio-separation process while reducing manufacturing costs.
This pilot run is an important validation of our cell-free platform, demonstrating that it performs reliably at scale and delivers strong results in the hands of an external partner.” — Damien ...
LOS ANGELES, CA / ACCESS Newswire / March 18, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of ...
An international research team led by the Levenberg Laboratory in the Faculty of Biomedical Engineering at the ...
US alliance to accelerate next‑generation oral monoclonal antibody therapies Liège, Belgium, and Roanoke (VA), USA, March 18, 2026 — Bio‑Sourcing SA (‘Bio-Sourcing’) and The Tiny Cargo Company (‘Tiny ...
Construction is expected to start in the second half of 2026, with commercialization in 2028, says Unibio CEO David Henstrom.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results